# ClinicalTrials.gov record NCT00690235

> PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide.

- Evidence object: `story:clinicaltrials-gov-nct00690235-pramlintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00690235-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00690235-pramlintide-v1.json
- Content SHA-256: `ca93dc383ef4720b627ec7b46c67e7106ba58ef7ef46305068bf9da5443f7b14`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00690235 ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`](#source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4))

## Sources

<a id="source-ctg-observation-nct00690235-2018-11-16-8e2070b489c4"></a>
- **ClinicalTrials.gov record NCT00690235 · retained source version 2018-11-16:8e2070b489c431b3d9b4ac02c0dea8608296451d243fe28784f47aa59cf5a340** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00690235) (`ctg-observation-nct00690235-2018-11-16-8e2070b489c4`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00690235." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00690235-pramlintide-v1.json SHA-256: ca93dc383ef4720b627ec7b46c67e7106ba58ef7ef46305068bf9da5443f7b14.